About Yieldstreet
Yieldstreet is an alternative investment platform that provides access to a range of asset classes, including real estate, marine finance, legal finance, art, and more. It is designed for accredited investors seeking to diversify their portfolios beyond traditional stocks and bonds. The platform fractionalizes investments, allowing individuals to participate in opportunities that were historically only available to large institutions or ultra-high-net-worth individuals. Yieldstreet’s offerings typically involve income-generating assets with varying risk profiles and target returns.
It is important to note that Yieldstreet is primarily an alternative investment platform and does not specialize in healthcare AI. While they may offer investments in companies within the healthcare sector, their core business model is focused on providing access to a broad spectrum of alternative assets rather than developing or deploying healthcare AI solutions themselves. Physicians interested in healthcare AI companies should be aware that Yieldstreet’s primary function is as an investment platform, not a direct healthcare AI developer.
Focus Areas
What Physicians Need to Know
For physicians looking to diversify their portfolios beyond traditional stocks and bonds, Yieldstreet (now Willow Wealth) offers access to a broad range of alternative investments like real estate, legal finance, art finance, and private credit. These alternative assets can potentially offer enhanced returns, current income, and diversified risks, with low correlation to the public market. Physicians, especially those who are accredited investors, can explore individual offerings or managed portfolios like Willow 360 for exposure to private markets. However, it's crucial to be aware that alternative investments often carry higher risks and are generally illiquid, meaning capital may be locked in for the deal's full term. Some of Yieldstreet's past real estate and marine finance offerings have resulted in investor losses and regulatory settlements, highlighting the importance of thorough due diligence and understanding the inherent risks. It is advisable for physicians to consider their risk tolerance and liquidity needs carefully before investing in such platforms.
Yieldstreet has integrated with IRA custodian Equity Trust to allow investors to add private market investments to self-directed IRAs, including traditional, Roth, SEP, or SIMPLE IRAs. They also partner with third-party asset managers like Carlyle, StepStone, and Goldman Sachs for their managed portfolios (Willow 360).
Products by Yieldstreet
What the Web Says
Yieldstreet, which rebranded to Willow Wealth in October 2025, is an online crowdfunding platform offering alternative investments like real estate, private credit, art, and venture capital. While it aims to provide diversification and potentially higher returns, the platform has faced significant criticism regarding investor losses and a high default rate on real estate investments. Many investors have reported losing substantial portions of their investments, with some alleging a lack of due diligence and poor communication from the company.
Overall: NegativeStrengths
- Broad access to alternative asset classes, including real estate, private credit, art, and venture capital.
- Offers opportunities for portfolio diversification beyond traditional stocks and bonds.
- Potentially higher returns compared to traditional investments.
- Some offerings are backed by assets, which may offer a degree of protection.
- Short-Term Notes product has a reliable track record of on-time payouts.
- Institutional fund partnerships provide access to funds from major financial institutions like Carlyle and Goldman Sachs for accredited investors.
Limitations
- Significant cumulative investor losses, with reports of investors losing their entire investments.
- High real estate default rate, estimated at around 30%, which is considerably higher than peer platforms.
- Investments are generally illiquid and require longer holding periods, with no formal early-exit options for most offerings.
- High fees compared to some competitors, with annual management fees ranging from 0% to 2.5%, and additional fund expenses.
- Limited options for non-accredited investors, primarily restricted to the Alternative Income Fund.
- Concerns about lack of transparency, poor communication, and inadequate due diligence on some deals.
- The company rebranded to Willow Wealth after a wave of investor losses, which some reviewers view with caution.
Based on reviews from: Reddit, Business Insider, Lofty.ai, MoneyRates, Angel Investors Network, WalletHub, WallStreetZen, Trustpilot
Last updated: 2026-10-01
Videos
News, demos, and interviews about Yieldstreet.
Videos load interactively. If none appear, search YouTube for Yieldstreet →
Press & Coverage
Frequently Asked Questions
Related Companies
OrthoAI is an innovative AI-powered platform designed to assist orthopedic surgeons in clinical decision-making, surgical planning, and patient care. It functions as a 24/7 surgical companion, providing evidence-based answers to complex clinical questions, surgical techniques, and theoretical queries. The platform leverages a meticulously curated database developed by expert orthopedic surgeons, integrates with PubMed for the […]
NuvoAir is a digital health company that provides a value-based specialty care platform focused on proactive, continuous virtual care for individuals with heart and lung conditions. The company aims to transform the diagnosis and management of chronic cardiopulmonary conditions by integrating advanced monitoring technology, data analytics, and evidence-based interventions delivered by a multidisciplinary team. NuvoAir’s […]
Infinite Biomedical Technologies, LLC (IBT) is a medical device company established in 1997 with roots at Johns Hopkins University. The company is dedicated to developing innovative solutions for individuals with upper limb loss and differences, aiming to transform laboratory research into practical medical devices. IBT focuses on advanced prosthetic control systems and related technologies to […]
The search results indicate that “Strain AI” is not a single, unified company serving physicians and healthcare providers in the traditional medical sense. Instead, the term “Strain AI” appears to be a general descriptor used by several distinct companies operating primarily in the cannabis industry, leveraging AI to recommend cannabis strains based on user preferences, […]
Samsung is a global technology leader that has significantly expanded its presence in the healthcare sector, leveraging its expertise in AI, imaging, and connected devices. The company aims to improve patient care and outcomes by providing advanced diagnostic solutions, personalized health insights, and integrated digital health platforms. Samsung’s healthcare initiatives focus on bridging the gap […]
Philips (Cardiologs) is a healthcare AI company that specializes in transforming cardiac diagnostics through medical-grade artificial intelligence and cloud technology. Their core offering is the Cardiologs Holter platform, which utilizes deep neural networks to analyze continuous ambulatory ECGs. This platform is designed to streamline ECG analysis, reduce reporting errors, and accelerate diagnostic reporting, ultimately empowering […]